Cue Biopharma (CUE) Research & Development (2017 - 2025)

Cue Biopharma has disclosed Research & Development across 9 years of filings, most recently posting $16.5 million for Q4 2025.

• Research & Development for Q4 2025 came in at $16.5 million, up 130.12% year-over-year; the trailing twelve-month figure through Dec 2025 was $37.7 million (up 3.99% YoY), and the FY2025 annual result was $37.7 million, up 3.99% from the prior year.
• Research & Development came in at $16.5 million for Q4 2025 at Cue Biopharma, up from $4.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $16.5 million in Q4 2025 to a low of $4.8 million in Q3 2025.
• The 5-year median for Research & Development is $9.7 million (2021), against an average of $9.7 million.
• Peak annual rise in Research & Development reached 130.12% in 2025, while the deepest fall reached 49.32% in 2025.
• Cue Biopharma's Research & Development stood at $11.5 million in 2021, then dropped by 1.47% to $11.3 million in 2022, then decreased by 3.93% to $10.9 million in 2023, then slumped by 34.01% to $7.2 million in 2024, then surged by 130.12% to $16.5 million in 2025.
• The last three Research & Development figures came in at $16.5 million (Q4 2025), $4.8 million (Q3 2025), and $7.9 million (Q2 2025), per Business Quant data.